245866
Study Dates:
Screening starts in mid of March 2021.
Trial Number
245866
Group
● Healthy Volunteer
● Smoking (No)
● Non-Childbearing Females
● Postmenopausal
Compensation
Up to: $2,710
Gender
Male, Female, Non-Smoker
Age
18-50
BMI
18.5-30kg/m2 and weight between 50Kg-110Kg
Additional Information
Inconvenience Allowance will be paid to you in 2 split payments. You will receive £1000.00 after completion of Day 15 and £1,710 upon completion of the end of the study visit
Please be aware the screening visit for this study will take 6 hours.
Details
The new medicine tested in this study is a compound being developed the for the potential treatment of some diseases of the immune system that involve inflammation.
The study drug will be administered underneath the skin, either as an injection over approximately 2 minutes, or as a single infusion using a syringe pump.
This study consists of 1 or 2 screening visits, 5 consecutive nights in-house and 7 follow-up visits.